Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong -- and History Is on Its Side.
Key PointsIntuitive Surgical is extending the lifetimes of some of its instruments...
Nasdaq News: Markets
More News
Ecolab Closes CoolIT Acquisition, Strengthens AI Cooling Portfolio
ECL's $4.75B CoolIT acquisition boosts its AI cooling portfolio and positions High-Tech as a major long-term growth engine.
Zacks
Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates Again
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
BFLY's Embedded Partner Unveils Breakthrough in Brain Imaging Tech
Butterfly Network's partner Aleph Neuro showcases non-invasive 3D brain imaging, highlighting the reach of its Ultrasound-on-Chip platform.
Zacks
Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast
Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast...
Yahoo! Finance: News
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAbbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, nutrition, and generic medicines...
Nasdaq News: Markets
Stryker Vs. Intuitive Surgical: Stryker's Joint-Replacement Moat Over Intuitive's Premium Valuation
Stryker Vs. Intuitive Surgical: Stryker's Joint-Replacement Moat Over Intuitive's Premium Valuation...
Yahoo! Finance: News
Artivion Secures FDA Approval for AMDS Hybrid Prosthesis Device
AORT's FDA approval for AMDS removes a key hospital adoption hurdle and opens access to an estimated $150 million annual U.S. market.
Zacks
Intuitive Surgical's Moat Is Getting Stronger. Is This the Closest Thing to a 'Forever' Stock?
Key PointsIntuitive Surgical's earnings have climbed progressively over time...
Nasdaq News: Markets
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.